The transaction is the latest example of firms developing artificial intelligence moving into the field of life sciences. This shift follows a broader pattern of AI laboratories acquiring assets in biology to diversify their research and operational scope.
Tuesday, October 20, 2026
Story
OpenAI Acquires Orchestra Bio to Enter Life Sciences
Business6 hours ago
The artificial intelligence research lab took over the operations of Orchestra Bio to expand its technical capabilities into biological study. First reported by Axios and Madison Mills, the acquisition of the biotechnology firm allows the company to apply its models to the life sciences sector.
Looking for more context or analysis?
Tilt chat provides reliable, tailored insights, alerts, and automations.